7 years ago

PBD Biotech Secures £400K to Expand Actiphage Testing

  • PBD Biotech, an agtech startup based in Thurston, UK, raised £400k in funding from New Anglia Capital, regional investment groups and individual angel investors

  • The company plans to use the capital to fund international trials and launch a suite of products

  • PBD Biotech has developed Actiphage, a sensitive test for bovine TB, Johne’s and other mycobacterial diseases in livestock, wildlife and exotics.

      • ProblemTechnology

      "making early detection of bovine TB and other mycobacterial diseases in livestock, wildlife and exotics easier and more accurate."

      Solution

      "developing Actiphage, a sensitive test that can identify the presence of live bacteria in blood, milk or other tissue in as little as six hours and distinguish between infected and vaccinated animals."

      Covered on